Back

Brain natriuretic peptide level in patients with hypertrophic cardiomyopathy

29 April 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 4 - Hypertrophic cardiomyopathy Hypertrophic cardiomyopathy HFA Premium Access Heart Failure 2017 - 4th World Congress on Acute Heart Failure

About the speaker

Photo
Mrs Alexandra Demkina

Scientific and Practical Clinical Center for Diagnostics and Telemedicine, Moscow (Russian Federation)

5 More presentations in this session

Presentation thumbnail
Predictors of ICD-related adverse events in patients with hypertrophic cardiomyopathy
Mr C. Klein (Lille, FR)
Presentation thumbnail
Impact of hypertrophy in left ventricular ejection fraction and myocardial strain: application of three-dimensional wall-motion tracking technology in hypertrophic cardiomyopathy
Doctor L. Marques (Sra. da Hora, PT)
Abstract
Presentation thumbnail
Assessment of left ventricular strain by three-dimensional wall-motion tracking technology: a study in hypertrophic cardiomyopathy
Doctor L. Marques (Sra. da Hora, PT)
Abstract
Presentation thumbnail
Myosin heavy chain and MAP-kinase activating death domain-containing gene polymorphisms in adults with hypertrophic cardiomyopathy
Miss A. Polyakova (Saint Petersburg, RU)
Presentation thumbnail
The role of soluble st2 and galectin-3 in hypertrophic cardiomyopathy assessed by cardiac magnetic resonance
Doctor M. Gawor (Warsaw, PL)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 4 - Hypertrophic cardiomyopathy

The Event

Event poster

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources